Plague Market Share, Trends and Overview, H1 2016: Hexa Reports

Hexa Reports

Market Research Reports and Insightful Company Profiles

Plague Market Size, Share, Global Analysis, Trends,

Outlook, Overview, Market Insights, Pipeline Review, H1

2016

Summary

Global Markets Direct's, 'Plague - Pipeline Review, H2 2016', provides an overview of the Plague pipeline

landscape.

The report provides comprehensive information on the therapeutics under development for Plague,

complete with analysis by stage of development, drug target, mechanism of action (MoA), route of

administration (RoA) and molecule type.

Browse Detail Report With TOC @

http://hexareports.com/report/plague-pipeline-review-h2-2016/details

The report also covers the descriptive pharmacological action of the therapeutics, its complete research

and development history and latest news and press releases. Additionally, the report provides an

overview of key players involved in therapeutic development for Plague and features dormant and

discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy

areas and nearly 3,000 indications. The report is built using data and information sourced from Global

Markets Direct's proprietary databases, company/university websites, clinical trial registries,

Hexa Reports

Market Research Reports and Insightful Company Profiles

conferences, SEC filings, investor presentations and featured press releases from company/university

sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic

review following a stringent set of processes to ensure that all the profiles are updated with the latest

set of information. Additionally, various dynamic tracking processes ensure that the most recent

developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios,

enhances decision making capabilities and helps to create effective counter strategies to gain...